吉利(00175.HK)重越牛熊線 將量產N95口罩過濾標準車載淨化系統
吉利(00175.HK)股價連續第七天穩步上揚,公司宣布將開啟內地首個達到「N95口罩級」過濾標準的車載淨化系統(變相給汽車帶上「N95口罩」)研發工作,並力爭20天內完成研發,30天內實現量產。該股今早反覆挑戰牛熊線(13.93元),現造13.98元,續升3.6%,暫為最好藍籌,成交3,208萬股,涉資4.4億元。
同業普遍反覆受壓,但上周獲花旗升價至80元的比亞迪(01211.HK)今早隨大市低開見44.9元獲承接,股價掉頭跟隨A股跑贏同業,最高見48元,現造47.55元,倒升4.3%,結束兩連吐,成交631萬股;其A股最多急漲9.4%高見63.36元人民幣,現造61.25元人民幣,升5.8%,成交已達2,527萬股。
恆指低開312點或1.1%,最低見報27,044獲承接,現造27,293,續吐110點或0.4%,成交額482億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.